Psychiatry & Neurology Doctors in Seven Fields, PA Accepting Medicare

4 Psychiatry & Neurology doctors found. Showing 1 - 4

Marnin Eli Fischbach, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 100 Northpointe Cir, Suite 306, Seven Fields, PA 16046 Phone: 724-772-4848    Fax: 724-772-4888

Dr. Michelle Barwell, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 100 Northpointe Cir, Suite 306, Seven Fields, PA 16046 Phone: 724-772-4848    Fax: 724-772-4888

Dr. Wade Wolowiec, D.O. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 100 Northpointe Cir Ste 306, Seven Fields, PA 16046 Phone: 724-772-4848

Dr. Pamela A Zalewski Georgevich, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 100 Northpointe Cir, Suite 306, Seven Fields, PA 16046 Phone: 724-772-4848    Fax: 724-772-4888

News Archive

Fight against obesity and heart disease gets new boost from public sector and industry

The battle against obesity, heart disease and other diet related health problems received a -4 Million boost today with the announcement of seven new research projects. The projects, taking place in universities and research institutes across the UK, are part of a partnership between two publicly-funded Research Councils and 15 companies.

E-cigarette use during pregnancy poses health risk for offspring all the way into adulthood

The use of e-cigarettes (vaping) during pregnancy poses a significant health risk for the offspring, impairing blood vessel function even into adulthood, according to a new study by researchers at West Virginia University's School of Medicine.

Hythiam to raise $7 million by selling its common stock to institutional investors

Hythiam, Inc. (NASDAQ:HYTM) announced today that it has entered into definitive agreements to sell 9,333,334 shares of its common stock at a price per share of $.75 to institutional investors pursuant to a registered direct offering, representing gross proceeds of approximately $7 million.

New findings can help identify people at increased risk of hydroxychloroquine-related retinopathy

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that higher doses, longer duration of use, chronic kidney disease and Asian race could all be independent risk factors for retinopathy in people using hydroxychloroquine, an antimalarial drug commonly used to treat lupus, rheumatoid arthritis and other diseases.

Remyelinating drug shows potential to improve vision in patients with MS

A team led by a biomedical scientist at the University of California, Riverside, reports a drug - an estrogen receptor ligand called indazole chloride (IndCl) - has the potential to improve vision in patients with multiple sclerosis, or MS.

Read more Medical News

› Verified 1 days ago